Bausch Health Companies (BHC) closed at $8.40 on November 9, 2026, up 2.7% from the previous close, on volume of 3,785,357 shares (30-day average 3,566,409).
Data as of November 9, 2026.
9-Nov-2026
| # | Date | Strategy | Legs | Contracts |
|---|---|---|---|---|
| 1 | Nov 9, 2026 | Put Spread | 13-Nov-268.5 : 9 P | 750 |
| 2-3 | The next 2 largest trades are for Premium members. Start a 7-day free trial | |||
Ranked by contracts: multi-leg trades of 200 or more contracts on one day, through Nov 9, 2026. See the 10 largest for 30, 60 and 90 days
PRNewswire (Fri, 6-Nov 7:00 AM ET)
Market Chameleon (Thu, 29-Oct 6:29 AM ET)
Bausch Health Plans to Redeem $643 Million of 8.500% Notes Due 2027 Using Cash on Hand
Market Chameleon (Thu, 29-Oct 3:11 AM ET)
Bausch Health Announces Full Redemption of 8.500% Senior Notes Due 2027
PRNewswire (Wed, 28-Oct 4:08 PM ET)
Bausch Health Announces US$50 Million Share Repurchase Program
PRNewswire (Wed, 28-Oct 4:06 PM ET)
BAUSCH HEALTH ANNOUNCES THIRD QUARTER 2026 RESULTS, RAISES GUIDANCE
PRNewswire (Wed, 28-Oct 4:01 PM ET)
PRNewswire (Mon, 19-Oct 8:00 AM ET)
PRNewswire (Mon, 12-Oct 8:00 AM ET)
Business Wire (Mon, 12-Oct 6:45 AM ET)
Bausch Health to Announce Third Quarter 2026 Results on October 28, 2026
PRNewswire (Tue, 6-Oct 7:01 AM ET)
Bausch Health Companies Inc is a world-wide specialty pharmaceutical, consumer health, and medical device company with a focus on branded products for the gastroenterology, hepatology, neurology and dermatology markets. The company reports revenue in five segments: Salix; International; Solta Medical; Diversified Products and Bausch + Lomb. It generates maximum of its revenue from the Bausch + Lomb segment.
Bausch Health Companies trades on the NYSE stock market under the symbol BHC.
As of November 9, 2026, BHC stock price climbed to $8.40 with 3,785,357 million shares trading.
BHC has a beta of 0.71, meaning it tends to be less sensitive to market movements. BHC has a correlation of 0.02 to the broad based SPY ETF.
BHC has a market cap of $3.14 billion. This is considered a Mid Cap stock.
Last quarter Bausch Health Companies reported $3 billion in Revenue and $1.77 earnings per share. This beat revenue expectation by $187 million and exceeded earnings estimates by $.56.
In the last 3 years, BHC traded as high as $11.46 and as low as $3.96.
The top ETF exchange traded funds that BHC belongs to (by Net Assets): DFIS, DFIC, DISV, DFAX, ISCF.
BHC has outperformed the market in the last year with a price return of +26.3% while the SPY ETF gained +13.3%. BHC has also outperformed the stock market ETF in the last 3 month and 2 week periods returning +34.4% and +32.3%, respectively, while the SPY returned -2.4% and -1.7%, respectively.
BHC support price is $7.91 and resistance is $8.45 (based on 1 day standard deviation move). This means that using the most recent 20 day stock volatility and applying a one standard deviation move around the stock's closing price, stastically there is a 67% probability that BHC shares will trade within this expected range on the day.
